Chong Kun Dang Pharmaceutical (185750) — Free Cash Flow Generation Index
Chong Kun Dang Pharmaceutical (185750) has a Free Cash Flow Generation Index of -5.04x as of March 2026. Free cash flow of ₩-62.02 Billion represents -5% of operating cash flow (₩12.32 Billion). Read Chong Kun Dang Pharmaceutical (185750) financial obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Chong Kun Dang Pharmaceutical Free Cash Flow Generation Index (2016–2025)
Historical FCF Generation Index trend for Chong Kun Dang Pharmaceutical across 10 annual periods. Explore Chong Kun Dang Pharmaceutical (185750) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Chong Kun Dang Pharmaceutical (2016–2025)
Year-by-year Free Cash Flow Generation Index for Chong Kun Dang Pharmaceutical. For the full company profile including market capitalisation, see 185750 market cap overview.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.66x | ₩-111.77 Billion | ₩67.36 Billion | ₩179.13 Billion | ▼ -5783.4% |
| 2024 | -0.03x | ₩-1.81 Billion | ₩64.29 Billion | ₩66.10 Billion | ▼ -103.6% |
| 2023 | 0.78x | ₩249.35 Billion | ₩318.16 Billion | ₩68.81 Billion | ▲ +261.9% |
| 2022 | 0.22x | ₩14.67 Billion | ₩67.73 Billion | ₩44.90 Billion | ▲ +107.2% |
| 2021 | -3.02x | ₩-38.94 Billion | ₩12.90 Billion | ₩48.24 Billion | ▼ -566.4% |
| 2020 | 0.65x | ₩67.51 Billion | ₩104.32 Billion | ₩32.64 Billion | ▼ -4.6% |
| 2019 | 0.68x | ₩52.43 Billion | ₩77.29 Billion | ₩21.84 Billion | ▲ +60.8% |
| 2018 | 0.42x | ₩17.99 Billion | ₩42.63 Billion | ₩21.92 Billion | ▼ -42.9% |
| 2017 | 0.74x | ₩60.35 Billion | ₩81.67 Billion | ₩19.79 Billion | ▼ -56.1% |
| 2016 | 1.68x | ₩97.23 Billion | ₩57.79 Billion | ₩39.44 Billion | — |